DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 90 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $14,313,000 | -21.4% | 319,202 | 0.0% | 0.48% | -25.1% |
| Q4 2020 | $18,217,000 | +43.3% | 319,202 | +28.8% | 0.63% | +12.6% |
| Q3 2020 | $12,709,000 | +11.7% | 247,748 | +30.1% | 0.56% | +4.8% |
| Q2 2020 | $11,376,000 | +183.6% | 190,482 | +95.5% | 0.54% | +113.9% |
| Q1 2020 | $4,011,000 | -51.2% | 97,432 | -73.2% | 0.25% | -23.0% |
| Q2 2019 | $8,211,000 | -2.8% | 364,105 | 0.0% | 0.33% | -3.8% |
| Q1 2019 | $8,451,000 | -34.4% | 364,105 | -40.6% | 0.34% | -43.7% |
| Q4 2018 | $12,873,000 | -50.2% | 613,281 | -8.1% | 0.60% | -31.0% |
| Q3 2018 | $25,836,000 | +28.2% | 667,262 | +30.3% | 0.87% | +19.6% |
| Q2 2018 | $20,154,000 | +132.2% | 512,180 | +18.3% | 0.73% | +114.7% |
| Q1 2018 | $8,679,000 | -8.0% | 433,060 | +4.0% | 0.34% | -9.3% |
| Q4 2017 | $9,438,000 | +70.1% | 416,342 | +42.5% | 0.38% | +62.3% |
| Q3 2017 | $5,548,000 | – | 292,147 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
| Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
| Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
| Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
| BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
| AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
| ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
| Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
| EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |